First Time Loading...
C

CTC Bio Inc
KOSDAQ:060590

Watchlist Manager
CTC Bio Inc
KOSDAQ:060590
Watchlist
Price: 8 250 KRW 1.85% Market Closed
Updated: May 15, 2024

Wall Street
Price Targets

Price Targets Summary
CTC Bio Inc

Wall Street analysts forecast CTC Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTC Bio Inc is 25 000 KRW .

Lowest
Price Target
Not Available
Average
Price Target
25 000 KRW
203% Upside
Highest
Price Target
Not Available
CTC Bio Inc Competitors:
Price Targets
002349
Jinghua Pharmaceutical Group Co Ltd
299% Upside
CURA
Curaleaf Holdings Inc
37% Upside
LQDA
Liquidia Corp
114% Upside
4551
Torii Pharmaceutical Co Ltd
14% Upside
MEGA
Mega Lifesciences PCL
22% Upside
300006
Chongqing Lummy Pharmaceutical Co Ltd
273% Upside
MRK
Merck & Co Inc
10% Upside
NATCOPHARM
Natco Pharma Ltd
7% Downside

Revenue
Forecast

Revenue Estimate
CTC Bio Inc

For the last 8 years the compound annual growth rate for CTC Bio Inc's revenue is 2%. The projected CAGR for the next 1 year is 1%.

2%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CTC Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CTC Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTC Bio Inc's stock price target?
Price Target
25 000 KRW

According to Wall Street analysts, the average 1-year price target for CTC Bio Inc is 25 000 KRW .

What is CTC Bio Inc's Revenue forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for CTC Bio Inc's revenue is 2%. The projected CAGR for the next 1 year is 1%.